"Noble Hospital is a tertiary care hospital in Hadapsar Pune that was formed due to the tireless efforts of Dr.Dileep Mane and his team. With 250 beds it is South East Pune’s 1st NABH Accredited Hospital, it is also the youngest Green OT Hospital offering an array of facilities under one roof. Noble Hospital provides transformative medical technologies & services that are changing the dynamics of patient care. Thus, Noble Hospital Annex came into existence in 2015 with 2 state-of-the-art Operation Theaters along with 50 beds dedicated to Oncology Ward & 27 to Nephrology Unit. Mission of the hospital is to provide high quality integrated healthcare to patients at an affordable cost. You can get the best medical care for you & your family."

During the past decade, Noble Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 7 clinical trials were completed, i.e. on average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Noble Hospital" #1 sponsor was "Allergan" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Vicore Pharma AB" with 3 trials sponsored, "Abbott Nutrition" with 2 trials sponsored and "Johnson & Johnson Private Limited" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Noble Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Cephalon" with 1 trials as a collaborator, "Hamilton Health Sciences Corporation" with 1 trials as a collaborator, "Lambda Therapeutic Research Ltd." with 1 trials as a collaborator and "McMaster Surgical Associates" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Noble Hospital" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Covid19" (2 trials) and "Acute Bacterial Skin and Skin Structure Infections" (1 trials). Many other conditions were trialed in "Noble Hospital" in a lesser frequency.

Most popular intervention types in "Noble Hospital" are "Drug" (24 trials), "Other" (3 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Amivantamab" (3 trials), "Carboplatin" (3 trials), "Relamorelin" (3 trials) and "C21" (2 trials). Other intervention names were less common.

The vast majority of trials in "Noble Hospital" are 28 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Noble Hospital". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Noble Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Noble Hospital, 4 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".